- Home
- ROIV vs PLNT Comparison
ROIV vs PLNT Comparison
Compare ROIV & PLNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROIV
- PLNT
- Stock Information
- Founded
- ROIV 2014
- PLNT 1992
- Country
- ROIV United Kingdom
- PLNT United States
- Employees
- ROIV N/A
- PLNT N/A
- Industry
- ROIV Biotechnology: Pharmaceutical Preparations
- PLNT Hotels/Resorts
- Sector
- ROIV Health Care
- PLNT Consumer Discretionary
- Exchange
- ROIV Nasdaq
- PLNT Nasdaq
- Market Cap
- ROIV 8.6B
- PLNT 8.1B
- IPO Year
- ROIV N/A
- PLNT 2015
- Fundamental
- Price
- ROIV $15.28
- PLNT $98.66
- Analyst Decision
- ROIV Strong Buy
- PLNT Buy
- Analyst Count
- ROIV 4
- PLNT 14
- Target Price
- ROIV $15.50
- PLNT $107.93
- AVG Volume (30 Days)
- ROIV 7.8M
- PLNT 1.0M
- Earning Date
- ROIV 11-11-2025
- PLNT 11-06-2025
- Dividend Yield
- ROIV N/A
- PLNT N/A
- EPS Growth
- ROIV N/A
- PLNT 23.13
- EPS
- ROIV N/A
- PLNT 2.24
- Revenue
- ROIV $23,233,000.00
- PLNT $1,166,489,000.00
- Revenue This Year
- ROIV N/A
- PLNT $20.61
- Revenue Next Year
- ROIV $281.14
- PLNT $9.70
- P/E Ratio
- ROIV N/A
- PLNT $44.57
- Revenue Growth
- ROIV N/A
- PLNT 12.54
- 52 Week Low
- ROIV $8.73
- PLNT $77.77
- 52 Week High
- ROIV $16.05
- PLNT $114.47
- Technical
- Relative Strength Index (RSI)
- ROIV 82.00
- PLNT 34.40
- Support Level
- ROIV $13.81
- PLNT $101.12
- Resistance Level
- ROIV $14.48
- PLNT $104.69
- Average True Range (ATR)
- ROIV 0.47
- PLNT 2.33
- MACD
- ROIV 0.22
- PLNT -0.37
- Stochastic Oscillator
- ROIV 81.67
- PLNT 6.70
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About PLNT Planet Fitness Inc.
Planet Fitness Inc is a franchisor and operator of fitness centers in the United States. The company's reportable segments are Franchise, Corporate-owned stores, and Equipment. Franchise segment includes operations related to its franchising business in the United States, Puerto Rico, Canada, Panama, Mexico and Australia, Corporate-owned stores segment includes operations with respect to all corporate-owned stores throughout the United States and Canada, and The Equipment segment includes the sale of equipment to franchisee-owned stores in the U.S. The firm generates a majority of its revenue from the Corporate-owned stores segment.